BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37817481)

  • 1. Cutaneous Involvement as a First Sign of CD5(-) Blastoid Mantle Cell Lymphoma.
    Zekey E; Öztürk Sarı Ş; Yeğen G; Darakcı S
    Balkan Med J; 2023 Oct; 40(6):456-459. PubMed ID: 37817481
    [No Abstract]   [Full Text] [Related]  

  • 2. CD5-negative blastoid variant mantle cell lymphoma: a diagnostic dilemma.
    Yamamoto N; Maeshima AM; Taniguchi H; Makita S; Fukuhara S; Munakata W; Suzuki T; Maruyama D; Izutsu K
    Hum Pathol; 2021 May; 111():84-91. PubMed ID: 33727166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinicopathologic features of mantle cell lymphoma and the significance of cyclin D1 in diagnosis].
    He X; Li G; Liu W; Lin Y; Li F; Liao D
    Zhonghua Bing Li Xue Za Zhi; 2002 Aug; 31(4):300-4. PubMed ID: 12417084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD10-positive blastoid mantle cell lymphoma with secondary cutaneous involvement.
    Phelps A; Gorgan M; Elaba Z; Pennington M; Norwood C; Rezuke W; Murphy MJ
    J Cutan Pathol; 2013 Aug; 40(8):765-7. PubMed ID: 23495728
    [No Abstract]   [Full Text] [Related]  

  • 5. Bilateral ocular panadnexal mass as initial presentation of systemic blastoid variant of mantle-cell lymphoma.
    Rašić DM; Knežević M; Terzić T; Vlajković G
    Surv Ophthalmol; 2017; 62(1):83-88. PubMed ID: 27256688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary cutaneous blastoid mantle cell lymphoma-case report.
    Estrozi B; Sanches JA; Varela PC; Bacchi CE
    Am J Dermatopathol; 2009 Jun; 31(4):398-400. PubMed ID: 19461249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blastoid mantle cell lymphoma with cutaneous involvement and aberrant immunophenotype.
    Phelps A; Elaba Z; Murphy MJ
    Am J Dermatopathol; 2014 Jun; 36(6):526-7. PubMed ID: 24061400
    [No Abstract]   [Full Text] [Related]  

  • 8. Blastoid Mantle Cell Lymphoma.
    Jain P; Wang M
    Hematol Oncol Clin North Am; 2020 Oct; 34(5):941-956. PubMed ID: 32861288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD5 negative mantle cell lymphoma: a different clinical entity?
    Alvarez-Argote J; Bauer FA; Dasanu CA
    Conn Med; 2014 Apr; 78(4):211-4. PubMed ID: 24830117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin D1-negative blastoid mantle cell lymphoma identified by SOX11 expression.
    Zeng W; Fu K; Quintanilla-Fend L; Lim M; Ondrejka S; Hsi ED
    Am J Surg Pathol; 2012 Feb; 36(2):214-9. PubMed ID: 22251940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mantle cell lymphoma with a unique pattern of CD5 expression: a case report with review of the literatures.
    Yamada T; Goto N; Tsurumi H; Takata K; Sato Y; Yoshino T; Moriwaki H; Kito Y; Takeuchi T; Iwata H
    Med Mol Morphol; 2014 Sep; 47(3):169-75. PubMed ID: 24166616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic features and management of blastoid variant of mantle cell lymphoma.
    Shrestha R; Bhatt VR; Guru Murthy GS; Armitage JO
    Leuk Lymphoma; 2015; 56(10):2759-67. PubMed ID: 25747972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mantle cell lymphoma involving skin: cutaneous lesions may be the first manifestation of disease and tumors often have blastoid cytologic features.
    Sen F; Medeiros LJ; Lu D; Jones D; Lai R; Katz R; Abruzzo LV
    Am J Surg Pathol; 2002 Oct; 26(10):1312-8. PubMed ID: 12360046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggressive Cyclin D1 Negative Blastoid Variant Mantle Cell Lymphoma-A Case Report.
    Loungani L; Mundhe R; Chinoy R
    Int J Surg Pathol; 2022 Apr; 30(2):190-194. PubMed ID: 34180720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mantle cell lymphoma: clinicopathologic features and prognostic factors of 102 cases occurring in Chinese patients].
    Ji H; Li GD; Li FY; Bai YQ; Chen Y; Yang MZ; Wang LJ; Tang Y; Zhang P; Xia T; Li C; Feng J; Zou ZK; Yixi JC
    Zhonghua Bing Li Xue Za Zhi; 2007 Nov; 36(11):730-5. PubMed ID: 18307875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blastoid variant mantle cell lymphoma with aberrant expression of CD10.
    Podvin B; Bossard JB; Pucalowski C; Bouchez G
    Ann Biol Clin (Paris); 2023 May; 81(2):222-223. PubMed ID: 37184256
    [No Abstract]   [Full Text] [Related]  

  • 17. Mantle cell lymphoma with skin invasion characterized by the common variant in the subcutis and blastoid transformation in the overlying dermis.
    Ishibashi M; Yamamoto K; Kudo S; Chen KR
    Am J Dermatopathol; 2010 Apr; 32(2):180-2. PubMed ID: 20010283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoldering mantle cell lymphoma.
    Ye H; Desai A; Zeng D; Nomie K; Romaguera J; Ahmed M; Wang ML
    J Exp Clin Cancer Res; 2017 Dec; 36(1):185. PubMed ID: 29246179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mantle cell lymphoma].
    Takhaev ZV; Probatova NA; Tupitsyn NN; Sholokhova EN
    Arkh Patol; 2002; 64(2):38-41. PubMed ID: 12107903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burkitt transformation of mantle cell lymphoma.
    Felten CL; Stephenson CF; Ortiz RO; Hertzberg L
    Leuk Lymphoma; 2004 Oct; 45(10):2143-7. PubMed ID: 15370262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.